MoneyWorks4Me

Jubilant Pharmova gets nod to sell, transfer API business to Jubilant Biosys

13 Jun 2025 Evaluate

Jubilant Pharmova has received approval for sale and transfer of the active pharmaceutical ingredients (API) business of the company on a slump sale basis to Jubilant Biosys (JBL), a wholly-owned subsidiary company, engaged in providing drug discovery services to global Pharmaceutical and Biotech companies.

The board of directors of the company in their meeting held on June 12, 2025 has approved the same.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..